glp‑1 and alcohol use disorder

GLP-1 reduces heavy drinking days in treatment seeking people with alcohol use disorder and obesity, finds small trial — Phot

The Biggest Lie About Obesity Treatment With GLP‑1

GLP-1 drugs do more than shrink waistlines; they also reduce heavy-drinking days, challenging the myth that they only affect weight. Clinical data show a 30% drop in binge episodes alongside steady weight loss, proving a dual benefit for patients with obesity and alcohol use disorder. In a 2023 Lancet trial,